stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Gross margin
Stevanato Group S.p.A.'s gross margin over the twelve months to 30 September 2026 was 29.1%, up 0.1 percentage points from fiscal 2025 (29.0%). Over the past ten years it has ranged from 24.3% (fiscal 2019) to 32.5% (fiscal 2022); the current reading is higher than 43% of that period. That is below the Medical Instruments & Supplies industry median of 53.6% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 29.0% | 1.61 |
| FY2024 | 27.4% | (3.94) |
| FY2023 | 31.3% | (1.19) |
| FY2022 | 32.5% | 1.06 |
| FY2021 | 31.5% | 2.12 |
| FY2020 | 29.3% | 5.04 |
| FY2019 | 24.3% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 29.1% | 0.37 |
| Jun 2026 | 28.8% | 1.27 |
| Mar 2026 | 27.5% | (3.25) |
| Dec 2025 | 30.7% | 1.54 |
| 22 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ATRC AtriCure, Inc. compare | 76.7% |
| NVST Envista Holdings Corporation compare | 55.9% |
| TFX Teleflex Incorporated compare | 54.9% |
| WRBY Warby Parker Inc. compare | 54.8% |
| MMED MiniMed Group, Inc. compare | 53.6% |
| MMSI Merit Medical Systems, Inc. compare | 49.4% |
| ICUI ICU Medical, Inc. compare | 40.3% |
| STVN Stevanato Group S.p.A. | 29.1% |
| PLSE Pulse Biosciences, Inc compare | 26.8% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement